SSA
ZSAN

Schonfeld Strategic Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-47
Closed -$62K – 831
2017
Q1 		$62K Buy
+47
New +$56.7K 0.01% 571

Other funds holding ZSAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's ZSAN Position: Q2 2017 in Review

Schonfeld Strategic Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q2 2017, closing a stake of 47 shares — an estimated $62K sold.

Schonfeld Strategic Advisors first reported a position in ZSAN in Q1 2017 and held it in 1 quarter. The position peaked at $62K in Q1 2017. 26 funds tracked by Wall St. Rank hold ZSAN as of Q2 2017.

  • Schonfeld Strategic Advisors reported no remaining Zosano Pharma Corporation position as of Q2 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 47 Zosano Pharma Corporation shares in Q2 2017, an estimated $62K.
  • Schonfeld Strategic Advisors first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Zosano Pharma Corporation position peaked at $62K in Q1 2017.
  • 26 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.